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Reply to Weber and Rutala
To the Editor—We read with interest the commentary by
Weber and Rutala.1 The authors discuss the contribution of
contaminated environmental surfaces within hospitals to
transmitting clinically relevant microorganisms frequently as-
sociated with healthcare infections. We welcome commen-
taries of this nature, since the potential for contaminated
environmental surfaces to contribute to the chain of health-
care-associated infections is often overlooked and under-
researched in favor of more well-publicized and documented
mechanisms, primarily the contaminated hands of healthcare
workers.
Self-disinfecting surfaces have been the focus of several
well-conducted research studies, including studies within our
research group.2 In the recent study by Karpanen et al,2 several
frequently touched items—including door handles, grab rails,
and toilet seats—in a hospital ward were replaced with equiv-
alent items produced from copper alloy and sampled for mi-
croorganisms. The study demonstrated a significant reduction
in the microbial bioload on copper as compared with non-
copper equivalents.
As Weber and Rutala1 state in their commentary, there are
limitations to the introduction of copper items in healthcare
facilities; however, this is often the case for implementing
many novel strategies in infection control, and one should
also consider the potential benefits. The data from the study
of Karpanen et al2 clearly highlight the value of self-disin-
fecting surfaces in reducing microbial bioloads from clinical
surfaces, and proactive infection control teams may wish to
give consideration to where copper surfaces may be of benefit
in their respective institutions, for example, in intensive care
units or areas with high numbers of immunocompromised
patients. An obvious issue is the cost of purchasing and im-
plementing copper items. To our knowledge, cost-effective-
ness studies have to date not been undertaken, and investi-
gations to address the added value of copper are therefore
clearly warranted, particularly in view of the considerable
costs associated with healthcare infections.3 The alternative
option is perhaps the inertia approach, allowing current en-
vironmental surfaces (eg, stainless steel, plastic) to remain
dominant in clinical settings. However, these surfaces do not
possess any antimicrobial activity and do not contribute to
breaking the chain of infection; this is not desirable, since
we aspire to design out infection in the modern world.
Copper is a highly efficacious antimicrobial and, as Weber
and Rutala1 state, has been effective in eliminating important
healthcare-associated pathogens. In the United Kingdom,
Clostridium difficile is currently one of the leading causes of
healthcare-associated infections, and while the number of
cases has declined over recent years, it is still a significant
cause of morbidity and mortality. Weber and Rutala1 com-
ment that copper has not been shown in vitro to kill dormant
spores of C. difficile. However, in the study by Weaver et al,4
copper was shown to kill dormant spores of C. difficile within
24–48 hours. Research undertaken by our group has also
shown that copper surfaces are highly effective in reducing
the viable bioload of C. difficile vegetative cells (NCTC 11204
and ribotype 027) by approximately 6 logs in both clean and
soiled conditions within 30 minutes at room temperature,
thus limiting the time for C. difficile to develop hardy, resistant
environmental spores.5,6 Furthermore, studies have also
shown that germinating spores of bacteria are more suscep-
tible to killing by disinfectants than dormant spores. At Aston
University, we have developed a patented germination so-
lution for C. difficile that renders spores susceptible to killing
by common biocides, including copper. In our research, we
have demonstrated that dormant spores become metaboli-
cally active and susceptible to copper surfaces in a short time
period following exposure to a C. difficile–specific, nontoxic
germination solution. Indeed, 99%–99.9% of germinant-
exposed spores (NCTC 11204 and ribotype 027) are elimi-
nated on both clean and soiled copper surfaces within 3
hours.
Weber and Rutala1 are correct when they state that it is
impractical or impossible to coat all environmental surfaces
and medical devices that could be potentially contaminated
with copper. However, a pragmatic approach may be to con-
sider designated areas that may benefit from a background
level of antimicrobial protection from copper surfaces sup-
plemented with routine infection control procedures and per-
haps novel germination solutions, as alluded to previously.
A previous criticism of copper items has been the aesthetic
issue, which may be potentially off-putting for patients, vis-
itors, and staff. However, there are now in excess of 300
different antimicrobial copper alloys that span a wide range
of colors and surface textures; these may be implemented
into clinical settings without disrupting the overall appear-
ance of the environment.
While the antimicrobial activity of copper surfaces has been
clearly demonstrated, it is important to appreciate that ef-
fective infection control relies on a bundle of mea-
sures—some already implemented into clinical practice and
some potentially on the horizon—and no single, stand-alone
approach is effective at controlling infection. We firmly be-
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lieve, on the basis of our studies and those of others, that
self-disinfecting surfaces such as copper are an important
additional tool and a significant step forward in helping to
reduce the potentially infection-causing microbial bioloads
that exist on clinical surfaces. Indeed, we should ask the ques-
tion, why select a nonantimicrobial surface when we now
know that naturally occurring metals have this intrinsic an-
timicrobial activity?
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Failure of HIV Postexposure Prophylaxis
after a Work-Related Needlestick Injury
To the Editor—Transmission of HIV by occupational needle-
stick injury (NSI) is a rare event,1,2 particularly in instances
in which a healthcare provider (HCP) receives prompt post-
exposure prophylaxis (PEP).3 We report a case in which PEP
failed to prevent HIV transmission.
After placement of a central line in a patient with cryp-
tococcal meningitis for whom HIV was recently diagnosed,
a HCP accidentally sustained a NSI to the left thumb with
the infiltration needle (25 gauge). The exposure site was
cleansed thoroughly with soap and water, and the HCP was
provided an antiretroviral regimen that consisted of lopinavir/
ritonavir, zidovudine, and lamivudine at the time the NSI
was reported (approximately 6 hours after exposure). How-
ever, the first doses of antiretroviral medication were not
administered until approximately 18 hours after exposure.
Serologic tests demonstrated that the source patient had neg-
ative results for hepatitis B and C, and the results of baseline
hepatitis and HIV tests for the exposed HCP were also neg-
ative. The source patient had received a diagnosis of HIV 1
day before his arrival, and he had never taken antiretrovirals.
He was transferred to another hospital and died less than 24
hours after the accident. No additional blood samples could
be recovered for further evaluation of the source patient. The
exposed HCP reported no high-risk sexual exposure, no in-
travenous drug use, and not having undergone HIV testing
before. On the 10th day following the exposure, the HCP
developed diarrhea (5–6 loose stools per day) without nausea
or vomiting, which was considered an adverse effect of the
PEP regimen. The regimen was changed to tenofovir (TDF),
emtricitabine (FTC), and atazanavir, which the HCP contin-
ued to receive without experiencing any further adverse ef-
fects. Ultimately, the HCP received a total of 4 weeks of PEP.
During the PEP period, the exposed HCP reported strict ad-
herence to both regimens, missing none of the doses. His
reports of adherence correlated with a controlled weekly pill
count. On the 25th day after exposure, the HCP remained
asymptomatic and the results of a second ELISA test for HIV
were negative. Approximately 60 days after exposure, the HCP
developed a dengue-like illness characterized by fever, throm-
bocytopenia, muscle pain, and fatigue; the physical exami-
nation at that time did not note either adenopathy or rash.
Antibody tests for dengue had negative results; however, an
ELISA for HIV had positive results (67 days after exposure).
The HCP’s symptoms subsequently disappeared with symp-
tomatic treatment. On day 74 after exposure, a second ELISA
test for HIV had positive results and the results of a Western
blot assay were indeterminate. At that time an HIV viral load
test was ordered, which detected 60,770 copies/mL with a
lymphocyte TCD4 count of 672 cells/mL. The HCP reported
that from the time of the NSI until the positive HIV test
results, he had no sexual contact or other risk factors for HIV
infection.
A blood sample for a genotype assay was collected on the
85th day after exposure (57 days after the last dose of PEP
antiretrovirals was administered). Resistance mutations se-
quenced (ViroSeq) for protease were V3I, E35D, S37D, Q61E,
L63P, I64V, C67S, H69Y, and V77I, and for reverse transcrip-
